Gemcitabine concurrent with radiation therapy for locally advanced head and neck carcinomas

African Health Sciences

Volumn 8, Issue 3, 2008, Pages 149-155

  Chauhan, Ashok ^a   Singh, Harmeet ^a   Sharma, Tejpal ^b   Manocha, K K ^a  

^a POST GRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

^b General Hospital   (India)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE; DEOXYCYTIDINE; DRUG DERIVATIVE; RADIOSENSITIZING AGENT;

ADULT; ADVANCED CANCER; ARTICLE; BLOOD TOXICITY; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CLINICAL PROTOCOL; CLINICAL TRIAL; COBALT TELETHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; ERYTHEMA; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HEAD AND NECK CARCINOMA; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; NAUSEA; ORAL MUCOSAL DISEASE; OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PROSPECTIVE STUDY; RADIATION DOSE; RADIOSENSITIVITY; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; SKIN TOXICITY; SQUAMOUS CELL CARCINOMA; STANDARD; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREATMENT OUTCOME; TREATMENT RESPONSE; VOMITING; WEIGHT REDUCTION; WORLD HEALTH ORGANIZATION; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; AGED; DOSE RESPONSE; DRUG ADMINISTRATION; HEAD AND NECK TUMOR; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOLOGY;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RADIATION-SENSITIZING AGENTS; RADIOTHERAPY, ADJUVANT; TREATMENT OUTCOME;

EID: 65349147643     PISSN: 16806905     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Vokes EE. Head and neck cancer. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson JD, Maltin JB, Kasper DL, et al, editors. Harrison's Principles of Internal Medicine. New York: Mc Graw Hill; 1998. p. 549-552.
2. Mohanti BK, Bahadur S, Lal P, Gairola M, Rath GK. Cancers of the head and neck. In: Rath GK, Mohanti BK, editors. Textbook of Radiation Oncology, Principles and Practice. New Delhi: B.I. Churchill Livingstone; 2000. p. 131-199.
3. Robson MC, Phillips LG. Head and neck: Over view. In: Moosa AR, Schimpff SC, Robson MC, editors. Comprehensive Text Book of Oncology. Baltimore: Williams & Wilkins; 1991. p. 1125-1207.
4. Tobias JS. Cancer of the head and neck. BMJ 1994; 308: 961-6.
5. Al-Sarraf M. Head and neck cancer: Chemotherapy concepts. Semin Oncol 1988; 15: 70-85.
6. Stupp R, Weichselbaum RR, Vokes EE. Combined modality therapy of head and neck cancer. Semin Oncol 1994; 21: 349-358.
7. Ervin TJ, Clark JR, Weichselbaum PR. An analysis of induction and adjuvant chemotherapy in the multidisciplinary treatment of squamous cell carcinoma of head & neck. J Clin Oncol 1987; 5: 10-20.
8. th ed. USA: W.B. Saunders Company; 2001. p. 1030-42.
9. Vokes EE, Haraf DJ, Kies MS.The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head & neck cancer. Semin Oncol 2000; 27 (4) (Suppl 8): 34-38.
10. Kumar A, Das BP, Hooda HS, Kaushal V, Manocha KK. Continuous hyperfractionated accelerated radiotherapy in head and neck carcinoma. Ind J Radiol Imag 1992; 2: 197-201.
11. Shewach DS, Hahn TM, Chang E. Metabolism of 2',2'-difluoro-2'- deoxycytidine and radiation sensitization of human colon carcinoma cells. Cancer Res 1994; 54: 3218-23.
12. Shewach DS, Lawrence TS. Radiosensitization of human solid tumour cell lines with gemcitabine. Semin Oncol 1996; 23(Suppl. 10): 65-71.
13. Lawrence TS, Chang EY, Hahn TM. Radiosensitization of pancreatic cells by 2',2'-di fluoro-2'-deoxycytidine. Int J Radiat Oncol Biol Phys 1996; 34: 867-72.
14. Lawrence TS, Eisbruch A, Schewach DS. gemcitabinemediated radiosensitization. Semin Oncol 1997; 24 (Suppl 7): 24.
15. Rockwell S, Grindey GB. Effect of 2',2-difluoro deoxycytidine on the viability and radiosensitivity of EMT6 Cells in vitro. Oncol Res 1992; 4: 151-55.
16. Eisbruch A, Shewach DS, Bradford CR. Radiation concurrent with gemcitabine for locally advanced head and neck cancer: a phase -I trial and intracellular drug incorporation study. J Clin Oncol 2001 Feb 1; 19(3): 792-99.
17. Benasso M, Merlano M, Sanguineti G et al. Gemcitabine, cisplatin, and radiation in advanced unresectable squamous cell carcinoma of the head and neck. Am J Clin Oncol 2001; 24: 618-622.
18. Milano MT, Haraf DJ, Stenson KM, Witt ME, Eng C, Mittal BB, Argiris A, Pelzer H, Kozloff MF, Vokes EE. Phase I Study of Concomitant Chemoradiotherapy with Paclitaxel, Fluorouracil, Gemcitabine, and Twice-Daily Radiation in Patients with Poor-Prognosis Cancer of the Head and Neck Clinical Cancer Research 2004;10: 4922-4932
19. Wildfang I, Raub M, Guner SA. Low dose gemcitabine with radiotherapy in advanced head and neck and thyroid cancer, a new radiosensitizing approach. J Can Res and Clin Oncol 2000; 126 (1): R40.
20. Huilgol NG, Roy S, Shah D, Chatterjee N. Gemcitabine once a week with Radical Radiation-A phase I trial. J Clin Radioth & Onco 2002; 2 (No.2): 30-33.